Journals / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 8

The effect of long-term systemic immunosuppressive drug use on druse formation: a new perspective to age-related macular degeneration

Pages
1963–1969
Publication Date
2022-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Patients who used long-term systemic immunosuppressive drugs had significantly lower hard and soft druse formation rate than age and sex matched control subjects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: To evaluate the effect of the long-term use of systemic immunosuppressive drugs on druse formation in patients aged over 50 years.
📊
Key Findings & Data:Materials and methods: The current retrospective cohort study includes 420 eyes of 420 patients. 210 eyes of 210 patients who used immunosuppressive drugs (Group 1) at least for the last 5 years and 210 eyes of 210 control patients (Group 2) who did not use any drugs were compared.
💡
Conclusion & Impact:Conclusion: Patients who used long-term systemic immunosuppressive drugs had significantly lower hard and soft druse formation rate than age and sex matched control subjects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: To evaluate the effect of the long-term use of systemic immunosuppressive drugs on druse formation in patients aged over 50 years. Materials and methods: The current retrospective cohort study includes 420 eyes of 420 patients. 210 eyes of 210 patients who used immunosuppressive drugs (Group 1) at least for the last 5 years and 210 eyes of 210 control patients (Group 2) who did not use any drugs were compared. All patients were older than 50 years and selected among patients who were followed by rheumatology and ophthalmology clinic at a tertiary university hospital. All patients had complete ophthalmic examination, fundus photography and optical coherence tomography (OCT). The primary outcome of this study is the difference in macular and paramacular druse formation rates between two groups. Results: Small, intermediate, large, soft, and paramacular druse formation rates were significantly lower in Group 1 than those in Group 2 (P = 0.028, P = 0.001, P = 0.001, P = 0.001, and P = 0.001, respectively). Conclusion: Patients who used long-term systemic immunosuppressive drugs had significantly lower hard and soft druse formation rate than age and sex matched control subjects.

🔖

Cite This Article

SEVER, Ö., MERCAN, R. (2022). The effect of long-term systemic immunosuppressive drug use on druse formation: a new perspective to age-related macular degeneration. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 8, 1963–1969. https://ajindex.com/articles/609804

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Friedman DS, O’Colmain BJ, Muñoz B, Tomany SC, McCarty C et al. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Archives of Ophthalmology 2004; 122 (4): 564-572. doi: 10.1001/archopht.122.4.564 2. Wong WL, Su X, Li X, Cheung CM, Klein R et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health 2014; 2 (2): 106-116. doi: 10.1016/S2214-109X(13)70145-1 2: 106–116 3. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. American Journal of Ophthalmology 2002; 134 (3): 411-431. doi: 10.1016/s0002-9394(02)01624-0 4. Spraul CW, Lang GE, Grossniklaus HE, Lang GK. Histologic and morphometric analysis of the choroid, Bruch’s membrane, and retinal pigment epithelium in postmortem eyes with agerelated macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Survey of Ophthalmology 1999; 44 (1): S10-S32. doi: 10.1016/s0039- 6257(99)00086-7 5. Li CM, Chung BH, Presley JB, Malek G, Zhang X et al. Lipoprotein-like particles and cholesteryl esters in human Bruch’s membrane: initial characterization. Investigative Ophthalmology & Visual Science 2005; 46 (7): 2576-2586. doi: 10.1167/iovs.05-0034 6. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proceedings of the National Academy of Sciences of the USA 2002; 99 (23): 14682-14687. doi: 10.1073/pnas.222551899 7. Johnson LV, Leitner WP, Staples MK, Anderson DH. Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Experimantal Eye Research 2001; 73 (6): 887-896. doi: 10.1006/ exer.2001.1094 8. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. Federation of American Societies for Experimental Biology 2000; 14 (7): 835-846. 9. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G et al. The International ARM Epidemiological Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Survey of Ophthalmology 1995; 39 (5): 367-374.